Dr. Sibel Blau is a Hematologist and Oncologist with special interest and expertise in breast cancer, multiple myeloma and stem cell transplant. She is the Medical Director at Northwest Medical Specialties, PLLC, where she also runs the clinical research and Precision Medicine program. She is one of the founding members and the President/CEO of the Quality Cancer Care Alliance Network (QCCA) that is a national organization with a focus of value-based care, education, and research as well as Exigent Research, an innovative research network of independent practices throughout the US to provide high quality, accelerated and accessible research to the communities where patients are treated. She is a board member and past President of Washington State Medical Oncology Society (WSMOS). She is involved in multiple committees at national organizations like ASCO, COA, ACCC. She is also a member of All4cure, which is a transparent platform for discussion between experts in myeloma, researchers, scientists and patients. She is the founder and president of the Journey Fund which is a community-based, not-for-profit organization committed to cancer patients facing barriers that affect their treatment with donations and community resources that make it possible for us to assist cancer patients facing social, financial, or emotional obstacles, toward a courageous journey, with dignity.